Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia

Leukemia and Lymphoma

Volumn 44, Issue 7, 2003, Pages 1239-1241

  Pou, Monica ^a   Saval, Nuria ^a   Vera, Manel ^a   Saurina, Anna ^a   Solé, Manel ^a   Cervantes, Francisco ^a   Botey, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic myeloid leukemia; Histologic study; Imatinib mesylate; Renal failure; STI571

Indexed keywords

ALPHA2B INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; PROTEIN TYROSINE KINASE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; PRIORITY JOURNAL; URINE VOLUME;

ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 0037986486     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000079140     Document Type: Article

References (8)

1. Rowley, J. (1973) "A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining", Nature 43, 290-293.
2. Daley, G.Q., Van Erten, R.A. and Baltimore, D. (1990) "Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gen of the Philadelphia chromosome", Science 247, 824-830.
3. Goldman, J., Szydlo, R., Horowitz, M.M., Gale, R.P., Ash, R.C., Atkinson, K., Dicke, K.A., Gluckman, E., Herzig, R.H. and Marmont, A. (1993) "Choice of pretransplant treatment and timing of transplant for chronic myelogenous leukemia in chronic phase", Blood 82, 2235-2238.
4. Druker, B., Talpaz, M., Resta, D., Bin Peng, R.N., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C. (2001) "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia", N. Engl. J. Med. 344, 1031-1037.
5. Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., Talpaz, M. and Drucker, B. (2002) "Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia", N. Engl. J. Med. 346, 645-652.
6. Kitiyakara, C. and Atichartakarn, V. (2002) "Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI571", NDT 17, 685-687.
7. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) "Effects of selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nat. Med. 2, 561-566.
8. Gilbert, R.E., Kelly, D.J., McKay, T., Chadban, S., Hill, PA., Cooper, M.E., Atkins, R.C. and Nikolic-Paterson, D.J. (2001) "PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis", Kidney Int. 59,